Diffusion-weighted imaging of the prostate: Comparison of b1000 and b2000 image sets for index lesion detection

Journal of Magnetic Resonance Imaging

Volumn 38, Issue 3, 2013, Pages 694-700

  Rosenkrantz, Andrew B ^a   Hindman, Nicole ^a   Lim, Ruth P ^a,c   Das, Kasturi ^b,d   Babb, James S ^a   Mussi, Thais C ^a,e   Taneja, Samir S ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c AUSTIN HEALTH   (Australia)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

^e HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

Author keywords

diffusion weighted imaging; MRI; Prostate cancer; prostatectomy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; DIFFUSION WEIGHTED IMAGING; GLEASON SCORE; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RETROSPECTIVE STUDY;

DIFFUSION-WEIGHTED IMAGING; MRI; PROSTATE CANCER; PROSTATECTOMY;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84883394503     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.24016     Document Type: Article

References (33)

1. Hoeks CM, Barentsz JO, Hambrock T, et al. Prostate cancer: multiparametric MR imaging for detection, localization, and staging. Radiology 2011; 261: 46-66.
2. Kim CK, Park BK, Kim B,. Diffusion-weighted MRI at 3 T for the evaluation of prostate cancer. AJR Am J Roentgenol 2010; 194: 1461-1469.
3. Haider MA, van der Kwast TH, Tanguay J, et al. Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. AJR Am J Roentgenol 2007; 189: 323-328.
4. Hambrock T, Somford DM, Huisman HJ, et al. Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer. Radiology 2011; 259: 453-461.
5. van As NJ, de Souza NM, Riches SF, et al. A study of diffusion-weighted magnetic resonance imaging in men with untreated localised prostate cancer on active surveillance. Eur Urol 2009; 56: 981-987.
6. Lim HK, Kim JK, Kim KA, Cho KS,. Prostate cancer: apparent diffusion coefficient map with T2-weighted images for detection-a multireader study. Radiology 2009; 250: 145-151.
7. Vilanova JC, Barcelo-Vidal C, Comet J, et al. Usefulness of prebiopsy multifunctional and morphologic MRI combined with free-to-total prostate-specific antigen ratio in the detection of prostate cancer. AJR Am J Roentgenol 2011; 196: W715-722.
8. Tanimoto A, Nakashima J, Kohno H, Shinmoto H, Kuribayashi S,. Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging. J Magn Reson Imaging 2007; 25: 146-152.
9. Katahira K, Takahara T, Kwee TC, et al. Ultra-high-b-value diffusion-weighted MR imaging for the detection of prostate cancer: evaluation in 201 cases with histopathological correlation. Eur Radiol 2011; 21: 188-196.
10. Metens T, Miranda D, Absil J, Matos C,. What is the optimal b value in diffusion-weighted MR imaging to depict prostate cancer at 3T? Eur Radiol 2012; 22: 703-709.
11. Kim CK, Park BK, Kim B,. High-b-value diffusion-weighted imaging at 3 T to detect prostate cancer: comparisons between b values of 1,000 and 2,000 s/mm2. AJR Am J Roentgenol 2010; 194: W33-37.
12. Kitajima K, Kaji Y, Kuroda K, Sugimura K,. High b-value diffusion-weighted imaging in normal and malignant peripheral zone tissue of the prostate: effect of signal-to-noise ratio. Magn Reson Med Sci 2008; 7: 93-99.
13. Bessede T, Soulie M, Mottet N, et al. Stage pT0 after radical prostatectomy with previous positive biopsy sets: a multicenter study. J Urol 2010; 183: 958-962.
14. Gross JL, Masterson TA, Cheng L, Johnstone PA,. pT0 prostate cancer after radical prostatectomy. J Surg Oncol 2010; 102: 331-333.
15. Epstein JI, Walsh PC, Carmichael M, Brendler CB,. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA 1994; 271: 368-374.
16. Rosenkrantz AB, Sigmund EE, Johnson G, et al. Prostate cancer: feasibility and preliminary experience of a diffusional kurtosis model for detection and assessment of aggressiveness of peripheral zone cancer. Radiology 2012; 264: 126-135.
17. Ahmed HU,. The index lesion and the origin of prostate cancer. N Engl J Med 2009; 361: 1704-1706.
18. Bott SR, Ahmed HU, Hindley RG, Abdul-Rahman A, Freeman A, Emberton M,. The index lesion and focal therapy: an analysis of the pathological characteristics of prostate cancer. BJU Int 2010; 106: 1607-1611.
19. Karavitakis M, Winkler M, Abel P, Livni N, Beckley I, Ahmed HU,. Histological characteristics of the index lesion in whole-mount radical prostatectomy specimens: implications for focal therapy. Prostate Cancer Prostatic Dis 2011; 14: 46-52.
20. Bostwick DG, Graham SD Jr, Napalkov P, et al. Staging of early prostate cancer: a proposed tumor volume-based prognostic index. Urology 1993; 41: 403-411.
21. McNeal JE,. Cancer volume and site of origin of adenocarcinoma in the prostate: relationship to local and distant spread. Hum Pathol 1992; 23: 258-266.
22. Jager GJ, Ruijter ET, van de Kaa CA, et al. Local staging of prostate cancer with endorectal MR imaging: correlation with histopathology. AJR Am J Roentgenol 1996; 166: 845-852.
23. Sommer FG, Nghiem HV, Herfkens R, McNeal J, Low RN,. Determining the volume of prostatic carcinoma: value of MR imaging with an external-array coil. AJR Am J Roentgenol 1993; 161: 81-86.
24. Kirkham AP, Emberton M, Allen C,. How good is MRI at detecting and characterising cancer within the prostate? Eur Urol 2006; 50: 1163-1174; discussion 75.
25. Mazaheri Y, Hricak H, Fine SW, et al. Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volume. Radiology 2009; 252: 449-457.
26. Langer DL, van der Kwast TH, Evans AJ, et al. Intermixed normal tissue within prostate cancer: effect on MR imaging measurements of apparent diffusion coefficient and T2-sparse versus dense cancers. Radiology 2008; 249: 900-908.
27. Turkbey B, Pinto PA, Mani H, et al. Prostate cancer: value of multiparametric MR imaging at 3 T for detection-histopathologic correlation. Radiology 2010; 255: 89-99.
28. Turkbey B, Mani H, Shah V, et al. Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds. J Urol 2011; 186: 1818-1824.
29. Tamada T, Sone T, Jo Y, et al. Prostate cancer: relationships between postbiopsy hemorrhage and tumor detectability at MR diagnosis. Radiology 2008; 248: 531-539.
30. Rosenkrantz AB, Kopec M, Kong X, et al. Prostate cancer vs. post-biopsy hemorrhage: diagnosis with T2- and diffusion-weighted imaging. J Magn Reson Imaging 2010; 31: 1387-1394.
31. Rosenkrantz AB, Mussi TC, Hindman N, et al. Impact of delay after biopsy and post-biopsy haemorrhage on prostate cancer tumour detection using multi-parametric MRI: A multi-reader study. Clin Radiol 2012; 67: e83-90.
32. Liu W, Laitinen S, Khan S, et al. Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer. Nat Med 2009; 15: 559-565.
33. Wise AM, Stamey TA, McNeal JE, Clayton JL,. Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens. Urology 2002; 60: 264-269.